Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-121232
Filing Date
2025-05-16
Accepted
2025-05-16 06:05:34
Documents
27
Period of Report
2025-06-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d787212ddef14a.htm   iXBRL DEF 14A 1785213
6 GRAPHIC g787212g09z00.jpg GRAPHIC 39452
7 GRAPHIC g787212g14i85.jpg GRAPHIC 38810
8 GRAPHIC g787212g40a09.jpg GRAPHIC 39452
9 GRAPHIC g787212g64a45.jpg GRAPHIC 161945
10 GRAPHIC g787212g64b89.jpg GRAPHIC 172817
11 GRAPHIC g787212g64v63.jpg GRAPHIC 135524
12 GRAPHIC g787212g81o70.jpg GRAPHIC 39049
13 GRAPHIC g787212g82a56.jpg GRAPHIC 74658
14 GRAPHIC g787212g84a65.jpg GRAPHIC 80036
15 GRAPHIC g787212g95f44.jpg GRAPHIC 28674
  Complete submission text file 0001193125-25-121232.txt   4490297

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sln-20241231.xsd EX-101.SCH 3466
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sln-20241231_def.xml EX-101.DEF 2551
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sln-20241231_lab.xml EX-101.LAB 2619
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sln-20241231_pre.xml EX-101.PRE 1652
30 EXTRACTED XBRL INSTANCE DOCUMENT d787212ddef14a_htm.xml XML 197500
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: DEF 14A | Act: 34 | File No.: 001-39487 | Film No.: 25956841
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)